Peak Bio
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Peak Bio generated cash of -$4,758,020, which is more than the previous year. Cash used in financing activities reached the amount of $4,281,285 last year. Net change in cash is therefore -$452,942.

Cash Flow

Peak Bio, Inc. (NASDAQ:PKBOW): Cash Flow
2019 -1.04K -488 11.95K
2021 -8.86M -9.88K 8.38M
2022 -7.48M -142.24K 8.13M
2023 -4.75M 0 4.28M

PKBOW Cash Flow Statement (2019 – 2023)

2023 2022 2021 2019
Cash at beginning of period
894.59K442.47K409.86K586
Operating activities
Net income
-12.82M-13.08M-8.29M-1.26K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
311.11K786.48K176.64K8
Stock-based compensation expense
275.41K560.06K4.89K0
Deferred income tax benefit 275.41K560.06K4.89K0
Changes in operating assets and liabilities:
Accounts receivable, net
09904
Inventories
0000
Accounts payable
2.23M816.03K-427.32K0
Cash generated by operating activities
-4.75M-7.48M-8.86M-1.04K
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
0-142.24K-9.88K-116
Acquisitions Net
0-1060-331
Cash generated by investing activities
0-142.24K-9.88K-488
Financing activities
Common Stock Issued
105.31K6.42M6.39M0
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
3.43M1.6M-1.99M0
Cash used in financing activities
4.28M8.13M8.38M11.95K
Net Change In Cash
-452.94K452.11K32.61K10.45K
Cash at end of period
441.64K894.59K442.47K11.04K
Data sourceData source